← Back to Search

Healthy for Atrial Fibrillation

Phase 2

Waitlist Available

Led By Matthew Doust, MD

Research Sponsored by Analog Device, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline

Awards & highlights

Study Summary

This trial will recruit and study up to 160 people to compare two ECG devices and how they measure heart activity. Medical personnel will analyze ECG results.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Sensitivity

Specificity

Secondary outcome measures

Clinical equivalence

Trial Design

2Treatment groups

Active Control

Group I: HealthyActive Control1 Intervention

Generally healthy participants that are able to participate in study procedures (i.e. laying down, sitting up, shaving chest hair for ECG/Test device placement if needed).

Group II: Atrial Fibrillation DiagnosisActive Control1 Intervention

Participants with a diagnosis of atrial fibrillation that are able to participate in study procedures (i.e. laying down, sitting up, shaving chest hair for ECG/Test device placement if needed).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Analog Device, Inc.Lead Sponsor

12 Previous Clinical Trials

1,890 Total Patients Enrolled

Hope Research InstituteUNKNOWN

Matthew Doust, MDPrincipal InvestigatorHope Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for participants in this clinical experiment?

"Per clinicaltrials.gov, this medical trial is not currently enrolling patients. Having been initially posted on May 19th 2022 and last updated on March 30th 2023, it appears that this study has concluded its recruitment process. However, there are still 484 other investigations actively seeking participants."

Answered by AI